Publications, Pharmaceutical

Aptar Pharma reviews the importance of silicone levels on vial stoppers

When developing new injectable drugs, manufacturers must consider the importance of primary packaging to ensure the drug is protected from the initial filling process to being administered to a patient. Silicone is added to every elastomeric closure component and is essential to ensure the products perform well on filling lines and in conjunction with the glass container. The PremiumCoat® platform of vial stoppers, pre-filled syringe plungers and services combine a state-of-the-art Bromobutyl formulation with a market proven ETFE film that help limit the transfer of extractables and leachables into the drug formulation.

For more information on ONdrugDelivery.

Author(s): Sébastien Cordier Vincent Holterboch Estelle Verger

16 May 2022

In this article, Aptar Pharma uses inductively coupled plasma optical emission spectrometry (ICP-OES) to demonstrate that our proprietary manufacturing process optimizes the distribution of silicone oil on our PremiumCoat®. By limiting the quantity of silicone that comes in contact with the drug product, PremiumCoat® derisks the development of sensitive drugs.

Learn more about PremiumCoat® Platform

Find Out More about PremiumCoat®

This Might Also Be of Interest

14 Dec 2022

Characterizing and Controlling Foreign Particulate Matters (FPM)

Webinars, Pharmaceutical, Product Solutions, Market Insights

14 Dec 2022

Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations

16 May 2022